David J. Brailer - 28 Feb 2024 Form 4 Insider Report for Cigna Group (CI)

Role
EVP & Chief Health Officer
Signature
Matthew Arnold, attorney-in-fact
Issuer symbol
CI
Transactions as of
28 Feb 2024
Net transactions value
$0
Form type
4
Filing time
01 Mar 2024, 19:44:22 UTC
Previous filing
05 Sep 2023
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Award $0 +3,121 +63% $0.000000 8,063 28 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Award $0 +11,369 $0.000000 11,369 28 Feb 2024 Common Stock, $.01 Par Value 11,369 $336.48 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted shares vest in three equal annual installments beginning March 1, 2025.
F2 This option vests in three equal annual installments beginning March 1, 2025.

Remarks:

Exhibit List: EX-24 Power of Attorney poabrailer.txt